Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04002479 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Alpha Radiation Emitters Device for the Treatment of Advanced Pancreatic Cancer

StatusActive, Not Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary completion date: Oct 2025 to Oct 2026
    • Trial status: Recruiting to Active, Not Recruiting
    • Site details revised at 2 of 2 sites
    v17
  2. Primary completion date: Oct 2024 to Oct 2025v16
  3. Site contacts updated at 2 of 2 sitesv15
  4. Enrollment target: 30 to 37v14
  5. Re-verified, no change to tracked fieldsv13
Show 11 earlier versionsHide 11 earlier versions
  1. Site details revised at 1 of 2 sitesv12
  2. Re-verified, no change to tracked fieldsv11
  3. Study sites: 1 to 2v10
  4. Primary completion date: Oct 2022 to Oct 2024
    • Study completion date: Oct 2024 to Oct 2026
    v9
  5. 2 versions Re-verified since Apr 11, 2022, no change to tracked fieldsv7-v8
  6. Trial status: Not Yet Recruiting to Recruitingv6 Show 4 more changesShow less
    • Primary completion date: Jan 2022 to Oct 2022
    • Study sites: 0 to 1
    • Study completion date: Jan 2024 to Oct 2024
    • Start date changed from estimate of Jul 2020 to Oct 20, 2020
  7. Start date: Jan 2020 to Jul 2020v5
  8. Primary completion date: Dec 2021 to Jan 2022
    • Study completion date: Dec 2023 to Jan 2024
    • Start date: Dec 2019 to Jan 2020
    v4
  9. Start date: Oct 2019 to Dec 2019
    • Primary completion date: Oct 2021 to Dec 2021
    • Study completion date: Oct 2023 to Dec 2023
    v3
  10. Primary completion date: Mar 2023 to Oct 2021v2 Show 5 more changesShow less
    • Study completion date: May 2023 to Oct 2023
    • Start date: Sep 2019 to Oct 2019
    • Eligibility criteria revised
    • Secondary endpoints: details revised at 3 of 6 entries
    • Study description shortened, about 53 words
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
A unique approach for cancer treatment employing intratumoral diffusing alpha radiation emitter device for advanced pancreatic cancer.
Trial Details
NCT Number NCT04002479
Lead Sponsor Alpha Tau Medical LTD.
Conditions
(from sponsor)		 Pancreatic Cancer, Unresectable Pancreatic Cancer, Metastatic Pancreatic Cancer, Pancreatic Adenocarcinoma
Related terms Pancreatic Neoplasms
Enrollment 37 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov